Mike Romanos named CEO of Crescendo
This article was originally published in Scrip
Executive Summary
Crescendo Biologics has appointed Mike Romanos chief executive officer. He has been chief scientific officer of the company since May 2009 and led the formation of the company and the development of its proprietary antibody fragment technologies.